ATE259818T1 - Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen - Google Patents
Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungenInfo
- Publication number
- ATE259818T1 ATE259818T1 AT01203116T AT01203116T ATE259818T1 AT E259818 T1 ATE259818 T1 AT E259818T1 AT 01203116 T AT01203116 T AT 01203116T AT 01203116 T AT01203116 T AT 01203116T AT E259818 T1 ATE259818 T1 AT E259818T1
- Authority
- AT
- Austria
- Prior art keywords
- spla2
- treating
- related diseases
- tricyclic compounds
- substituted tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6216598A | 1998-04-17 | 1998-04-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE259818T1 true ATE259818T1 (de) | 2004-03-15 |
Family
ID=22040624
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01203116T ATE259818T1 (de) | 1998-04-17 | 1999-04-16 | Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen |
AT99302969T ATE254128T1 (de) | 1998-04-17 | 1999-04-16 | Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99302969T ATE254128T1 (de) | 1998-04-17 | 1999-04-16 | Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen |
Country Status (27)
Country | Link |
---|---|
EP (2) | EP0950661B1 (de) |
JP (1) | JP4435325B2 (de) |
KR (1) | KR19990083234A (de) |
CN (1) | CN1235968A (de) |
AR (1) | AR018185A1 (de) |
AT (2) | ATE259818T1 (de) |
AU (1) | AU757454B2 (de) |
BR (1) | BR9901275A (de) |
CA (1) | CA2269256A1 (de) |
CO (1) | CO5080728A1 (de) |
CZ (1) | CZ137199A3 (de) |
DE (2) | DE69914951T2 (de) |
EA (1) | EA003129B1 (de) |
ES (2) | ES2213668T3 (de) |
HU (1) | HUP9901219A1 (de) |
ID (1) | ID23219A (de) |
IL (1) | IL129484A0 (de) |
NO (1) | NO991823L (de) |
NZ (1) | NZ335252A (de) |
PE (1) | PE20000472A1 (de) |
PL (1) | PL332564A1 (de) |
SG (1) | SG106035A1 (de) |
SV (1) | SV1999000052A (de) |
TR (1) | TR199900842A2 (de) |
TW (1) | TW555760B (de) |
YU (1) | YU19099A (de) |
ZA (1) | ZA992773B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9123198A (en) * | 1997-08-28 | 1999-03-16 | Eli Lilly And Company | Method for treatment of non-rheumatoid athritis |
WO2001074817A1 (fr) * | 2000-03-30 | 2001-10-11 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'hydrazide |
BR0112460A (pt) * | 2000-07-14 | 2003-07-22 | Lilly Co Eli | Método para tratamento de sépsis |
AU2002239264A1 (en) * | 2000-12-18 | 2002-07-01 | Eli Lilly And Company | Tetracyclic derivatives as spla2 inhibitors |
DE60218155D1 (de) | 2001-03-28 | 2007-03-29 | Lilly Co Eli | Substituierte carbazole als inhibitoren von spla2 |
JP2005527464A (ja) | 2001-08-09 | 2005-09-15 | イーライ・リリー・アンド・カンパニー | sPLA2インヒビターとしてのシクロヘプタBインドール誘導体 |
DE60208065T2 (de) | 2001-08-09 | 2006-07-13 | Eli Lilly And Co., Indianapolis | Cyclohept'b! indolderivate als spla2-inhibitoren |
US6992100B2 (en) | 2001-12-06 | 2006-01-31 | Eli Lilly And Company | sPLA2 inhibitors |
AU2005302559A1 (en) | 2004-11-01 | 2006-05-11 | Wyeth | Substituted indolizines and derivatives as CNS agents |
ES2523580T3 (es) | 2008-01-11 | 2014-11-27 | Albany Molecular Research, Inc. | Piridoindoles substituidos con (1-Azinona) |
WO2011003021A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
US8993765B2 (en) | 2010-12-21 | 2015-03-31 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof |
PT2697223T (pt) * | 2011-04-14 | 2016-10-14 | Actelion Pharmaceuticals Ltd | Derivados de ácido 7-(heteroaril-amino)-6,7,8,9-tetraidropirido[1,2-a]indolacético e utilização dos mesmos como moduladores do recetor d2 de prostaglandina |
WO2013138565A1 (en) | 2012-03-16 | 2013-09-19 | Vitae Pharmaceuticals, Inc. | Liver x receptor modulators |
BR112014022780A8 (pt) | 2012-03-16 | 2021-06-15 | Vitae Pharmaceuticals Inc | composto modulador de receptor de fígado x, composição farmacêutica que o compreende e seu uso |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3979391A (en) * | 1972-11-22 | 1976-09-07 | Sterling Drug Inc. | 1,2,3,4-Tetrahydrocarbazoles |
PT95692A (pt) * | 1989-10-27 | 1991-09-13 | American Home Prod | Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase |
IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
EP0772596B1 (de) * | 1994-07-21 | 2003-10-01 | Eli Lilly And Company | Indolizin spal2 inhibitoren |
ATE203744T1 (de) * | 1995-12-13 | 2001-08-15 | Lilly Co Eli | Naphthyl-acetamide als spla2-inhibitoren |
IL129481A0 (en) * | 1996-10-30 | 2000-02-29 | Lilly Co Eli | Substituted tricyclics |
EP1007056A1 (de) * | 1997-09-26 | 2000-06-14 | Eli Lilly And Company | Verfahren zur behandlung von zystischer fibrose |
EP1043991A4 (de) * | 1997-11-14 | 2005-02-02 | Lilly Co Eli | Behandlung der alzheimer-erkrankung |
-
1999
- 1999-04-15 IL IL12948499A patent/IL129484A0/xx unknown
- 1999-04-15 ID IDP990342D patent/ID23219A/id unknown
- 1999-04-16 DE DE69914951T patent/DE69914951T2/de not_active Expired - Fee Related
- 1999-04-16 EP EP99302969A patent/EP0950661B1/de not_active Expired - Lifetime
- 1999-04-16 CN CN99108097A patent/CN1235968A/zh active Pending
- 1999-04-16 AU AU23818/99A patent/AU757454B2/en not_active Ceased
- 1999-04-16 EA EA199900304A patent/EA003129B1/ru not_active IP Right Cessation
- 1999-04-16 SV SV1999000052A patent/SV1999000052A/es not_active Application Discontinuation
- 1999-04-16 EP EP01203116A patent/EP1156050B1/de not_active Expired - Lifetime
- 1999-04-16 AT AT01203116T patent/ATE259818T1/de not_active IP Right Cessation
- 1999-04-16 TW TW088106131A patent/TW555760B/zh not_active IP Right Cessation
- 1999-04-16 DE DE69912670T patent/DE69912670T2/de not_active Expired - Fee Related
- 1999-04-16 NZ NZ335252A patent/NZ335252A/xx unknown
- 1999-04-16 AR ARP990101769A patent/AR018185A1/es not_active Application Discontinuation
- 1999-04-16 CO CO99022891A patent/CO5080728A1/es unknown
- 1999-04-16 PL PL99332564A patent/PL332564A1/xx not_active Application Discontinuation
- 1999-04-16 ZA ZA9902773A patent/ZA992773B/xx unknown
- 1999-04-16 JP JP10965699A patent/JP4435325B2/ja not_active Expired - Fee Related
- 1999-04-16 NO NO991823A patent/NO991823L/no not_active Application Discontinuation
- 1999-04-16 TR TR1999/00842A patent/TR199900842A2/xx unknown
- 1999-04-16 KR KR1019990013439A patent/KR19990083234A/ko not_active Application Discontinuation
- 1999-04-16 PE PE1999000321A patent/PE20000472A1/es not_active Application Discontinuation
- 1999-04-16 HU HU9901219A patent/HUP9901219A1/hu unknown
- 1999-04-16 SG SG9901844A patent/SG106035A1/en unknown
- 1999-04-16 ES ES01203116T patent/ES2213668T3/es not_active Expired - Lifetime
- 1999-04-16 YU YU19099A patent/YU19099A/sh unknown
- 1999-04-16 ES ES99302969T patent/ES2210979T3/es not_active Expired - Lifetime
- 1999-04-16 CA CA002269256A patent/CA2269256A1/en not_active Abandoned
- 1999-04-16 BR BR9901275-8A patent/BR9901275A/pt not_active IP Right Cessation
- 1999-04-16 CZ CZ991371A patent/CZ137199A3/cs unknown
- 1999-04-16 AT AT99302969T patent/ATE254128T1/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE255888T1 (de) | Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten | |
DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
ATE251903T1 (de) | Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen | |
ATE236529T1 (de) | Antiparasitäre zusammensetzung zur behandlung und zum schutz von haustieren | |
DE69920019D1 (de) | Behandlung von mineralfüllstoffen mit phosphaten, diese füllstoffe und deren verwendung | |
DE69812603D1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
ATE267015T1 (de) | Verbindungen und verfahren zur behandlung von krebs | |
DE69831222D1 (de) | Verbindungen zur immundiagnose von prostatakrebs und deren verwendung | |
DE69612649D1 (de) | Indolinonverbindungen zur behandlung von krankheiten | |
ATE241977T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen | |
ATE230617T1 (de) | Verfahren und methode zur behandlung von abfällen | |
DE69906671D1 (de) | Substituierte 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanone, deren Verwendung zur Behandlung von Erkrankungen des zentralen und periphären Nervensystems und diese enthaltende pharmazeutische Zusammensetzungen | |
DE60013859D1 (de) | Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis | |
ATE254128T1 (de) | Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen | |
ATE227127T1 (de) | Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes | |
DE69841984D1 (de) | Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen | |
DE69734296D1 (de) | Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b | |
DE69835419D1 (de) | Verfahren zur Behandlung von organischem Abwasser | |
DE69840752D1 (de) | Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen | |
DE60027429D1 (de) | Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien | |
ATE258062T1 (de) | Verwendung von wachstumshormon freisetzenden stoffen und ihren antagonisten zur behandlung von tumoren | |
ATE222910T1 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
DE69925578D1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |